Raffa, R. B. (2011). Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment. Journal of Clinical Pharmacy & Therapeutics, 36(4), 437. https://doi.org/10.1111/j.1365-2710.2010.01208.x
Chicago Style (17th ed.) CitationRaffa, R. B. "Cancer 'Survivor-care': I. the α7 NAChR as Potential Target for Chemotherapy-related Cognitive Impairment." Journal of Clinical Pharmacy & Therapeutics 36, no. 4 (2011): 437. https://doi.org/10.1111/j.1365-2710.2010.01208.x.
MLA (9th ed.) CitationRaffa, R. B. "Cancer 'Survivor-care': I. the α7 NAChR as Potential Target for Chemotherapy-related Cognitive Impairment." Journal of Clinical Pharmacy & Therapeutics, vol. 36, no. 4, 2011, p. 437, https://doi.org/10.1111/j.1365-2710.2010.01208.x.